Switzerland, US Agreement On GMP Inspections Comes Into Play

 
• By Vibha Sharma

An agreement between Switzerland and the US means that the competent authority of the importing country can now rely on the manufacturing inspections of the partner authority.

Flags of Switzerland and the USA against the background of the blue sky
The Swiss-US MRA can help avoid duplicate inspections of drug manufacturers • Source: Shutterstock

A mutual recognition agreement (MRA) between the Swiss and US regulatory agencies on good manufacturing practice (GMP) inspections of drug companies signed earlier this year has come into effect, paving the way for reduced administrative and financial burden on both industry and regulatory authorities in the two regions.

The agreement came into effect on 27 July after Swissmedic and the Food and Drug Administration finished scrutinizing each other’s processes for monitoring medicinal

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance